Baron Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Buy
8,953
+423
+5% +$55.7K 0.29% 40
2026
Q1
$1.19M Buy
8,530
+137
+2% +$19.2K 0.36% 31
2025
Q4
$1.03M Buy
8,393
+297
+4% +$36.1K 0.32% 40
2025
Q3
$899K Buy
8,096
+459
+6% +$52.2K 0.3% 42
2025
Q2
$847K Buy
7,637
+869
+13% +$92.5K 0.3% 41
2025
Q1
$758K Buy
6,768
+3,009
+80% +$310K 0.33% 42
2024
Q4
$347K Buy
+3,759
New +$338K 0.16% 105

Other funds holding GILD

Baron Wealth Management's GILD Position: Q2 2026 in Review

Baron Wealth Management increased its Gilead Sciences (GILD) stake by 5% in Q2 2026, buying an estimated $55.7K and bringing the position to 8,953 shares worth $1.13M. The position accounts for 0.29% of the portfolio, ranked #40.

Baron Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.19M in Q1 2026. 691 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Baron Wealth Management held 8,953 shares of Gilead Sciences worth $1.13M as of Q2 2026.
  • Baron Wealth Management bought 423 Gilead Sciences shares in Q2 2026, an estimated $55.7K.
  • Gilead Sciences made up 0.29% of Baron Wealth Management's portfolio in Q2 2026, its #40 holding.
  • Baron Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Baron Wealth Management's Gilead Sciences position peaked at $1.19M in Q1 2026.
  • 691 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Baron Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.